Leman Biotech’s Post

View organization page for Leman Biotech, graphic

1,996 followers

Leman Biotech is pleased to announce its oral presentation to be delivered at ASGCT 2024 in Baltimore! This time, Leman Biotech will present its updated clinical data (cut-off March 18, 2024 ) and share more cases of the IIT clinical trials on Meta 10-19 CAR-T cell therapy for relapsed or refractory CD19+ B cell hematological malignancies. The oral presentation (9:15 am to 9:30 am) will be part of the Late-Breaking Abstracts II scheduled at 8:00 am to 9:45 am in Ballroom 4. Welcome to join us then! #cart #carttherapy #cellandgenetherapy #celltherapy #cancertherapy #hematologies #ASGCT #ASGCT2024

Leman Biotech Announces Oral Presentation of Updated IIT Clinical Trial Results for Metabolically Armed CD19 CAR-T Cells at ASGCT 2024

Leman Biotech Announces Oral Presentation of Updated IIT Clinical Trial Results for Metabolically Armed CD19 CAR-T Cells at ASGCT 2024

Leman Biotech on LinkedIn

To view or add a comment, sign in

Explore topics